Change over period: —
NSE · MOLBIO
MOLBIO
-4.9% from the 52-week high · +44.5% above the low
1 · The price
How has the stock traded?
MOLBIO trades 4.9% below its 52-week high and 44.5% above its 52-week low.
2 · The business
Is it growing?
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Jun 2026 | |
|---|---|
| Revenue | 408 |
| Net profit | 59 |
| Net margin % | 14.4 |
| EPS (₹) | 5.1 |
4 · The owners
Who holds it, and are they adding?
+9 versus the previous month.
Mutual fund holdings · Oct 2026
30 schemes hold this stock
21 the month before.
- Kotak Healthcare Fund4.74% of NAV
- Kotak Focused Fund2.33% of NAV
- EDELWEISS RECENTLY LISTED IPO FUND2.22% of NAV
- Kotak Aggressive Hybrid Fund2.14% of NAV
- HDFC Pharma and Healthcare Fund1.87% of NAV
- Mirae Asset Healthcare Fund1.69% of NAV
- Kotak Contra Fund1.3% of NAV
- PGIM INDIA RETIREMENT FUND1.18% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for MOLBIO are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Quick answers
Common questions about MOLBIO
What is the MOLBIO share price?
MOLBIO (MOLBIO) last closed at ₹1,526.40, up 1.92% on the day. Its 52-week range is ₹1,036.65 to ₹1,574.40.
What is the market cap of MOLBIO?
MOLBIO has a market capitalisation of about ₹17,264 crore. Its price-to-earnings ratio is 102.0.
How many mutual funds hold MOLBIO?
30 mutual fund schemes held MOLBIO in October 2026. That compares with 21 the month before.
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.